Alnylam, Isis introduce new Regulus CEO

12/3/2007 | Forbes

Kleanthis G. Xanthopoulos has been appointed president and chief executive of Regulus Therapeutics LLC, a joint venture between Alnylam Pharmaceuticals and Isis Pharmaceuticals that focuses on microRNA technology. Xanthopoulos joins the company from Anadys Pharmaceuticals, where he was co-founder, former president and CEO.

View Full Article in:

Forbes

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Behavioral Health Operations
Meridian Health Plan
Detroit, MI
Medical Director
PacificSource
Bend, OR
Clinical Appeals RN
MJHS
Brooklyn, NY
Director of Clinical Operations
Meridian Health Plan
Detroit, MI
Sr. Director, Regulatory Compliance Intelligence and Outreach
Johnson & Johnson
New Brunswick, NJ